SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
BlackRock Capital Allocation Trust (BCAT) trades at a trailing P/E of 7.2. Trailing earnings yield is 13.91%. PEG 0.51 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (7.2); PEG ≤ 1.0 — Peter Lynch undervalued (0.51); earnings yield beats bond yields (13.91%).
- PEG Ratio 0.51 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 13.91% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 78/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — BCAT
Valuation Multiples
P/E (TTM)7.2
Forward P/EN/A
PEG Ratio0.51
Forward PEGN/A
P/B Ratio0.00
P/S Ratio7.10
EV/EBITDA0.0
Per Share Data
EPS (TTM)$2.09
Book Value / Share$0.00
Revenue / Share$2.12
FCF / Share$0.00
Yields & Fair Value
Earnings Yield13.91%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2020 |
$1.15 |
$128.56M |
$128.43M |
99.9% |
| 2021 |
$1.10 |
$124M |
$121.29M |
97.8% |
| 2022 |
$-2.81 |
$-320.36M |
$-322.52M |
- |
| 2023 |
$1.78 |
$206.9M |
$204.72M |
98.9% |
| 2024 |
$1.83 |
$197.67M |
$194.42M |
98.4% |
| 2025 |
$2.09 |
$225.03M |
$221.99M |
98.7% |
